Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’s Disease—Data from a Real World Cohort

Background: Reducing the progress of neurodegeneration is a key goal in Huntington´s disease (HD). A previously performed systematic screening for medications with neuroprotective features identified tricyclic antidepressants and neuroleptics as neuroprotective and mitochondrioprotective agents. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Achenbach, Jannis, Saft, Carsten, Faissner, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064332/
https://www.ncbi.nlm.nih.gov/pubmed/33805940
http://dx.doi.org/10.3390/brainsci11040413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064332/
https://www.ncbi.nlm.nih.gov/pubmed/33805940
http://dx.doi.org/10.3390/brainsci11040413

Ejemplares similares